Array BioPharma Inc (NASDAQ:ARRY) - Overview

Stock Report

Array BioPharma Inc ARRY

Last Price
$7.92

Day Change
-0.18|-2.16%

As of 01/12/2016
16:00:00 EST | USD
Minimum 15 Minutes Delay.

Last Close8.10
Day Range7.81 - 8.16
Mkt Cap1.34Bil
52-Wk Range2.39 - 8.27
Yield %-
ISINUS04269X1054
Volume4,275,912
P/E-11.31
P/S7.07
P/CF-17.38

Share Price

Financials
201420152016
More ...
Income Statement
Revenue42.0851.91137.88
Operating Income-75.621.65-82.21
Net Income-85.269.37-92.84
Basic EPS-0.690.07-0.65
Avg. Diluted Shares Outstanding123142143
Balance Sheet
Current Assets121.68191.05155.30
Non Current Assets17.387.1613.60
Total Assets139.05198.21168.90
Current Liabilities52.7342.4252.43
Total Liabilities164.77155.55206.83
Total Equity-25.7242.65-37.93
Cash Flow
Operating Cash Flow-71.68-5.79-70.09
Capital Expenditure-2.61-2.51-3.16
Free Cash Flow-74.30-8.30-73.25

In millions, except "Basic EPS". Currency is USD.

Company Profile

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Blend

Fiscal Year Ends

June

Employees

-
Key Stats
More ...
Price/Earning TTM-11.56
Price/Book-26.17
Price/Sales TTM8.39
Rev Growth (3 year avg)25.60
EPS Growth (3 year avg)-
Operating Margin % TTM-59.62
Net Margin % TTM-67.33
ROE TTM-3,933.07
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.